Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV/TB Patients
NCT00474435Phase 2Unknown
- Sponsor
- APRIORI
- Start
- Nov 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emtricitabine, tenofovir, efavirenz in human immunodeficiency virus infection (HIV), sponsored by APRIORI. Status: unknown.
02
Drugs
emtricitabinetenofovirefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00474435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00474435.